Evidence map›Paper›PMID 34351392›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021.

Alexander Lawandi, Sarah Warner, Junfeng Sun, Cumhur Y Demirkale, Robert L Danner, Michael Klompas, Adi Gundlapalli, Deblina Datta, Aaron M Harris, Sapna Bamrah Morris and 2 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Reinfection with SARS-CoV-2 in a patient undergoing chemotherapy for lymphoma: Case report.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2022
    Article
  18. Suspected reinfections of SARS-COV-The Journal of infection · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alexander LawandiCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Sarah WarnerCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Junfeng SunCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Cumhur Y DemirkaleCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Robert L DannerCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
Michael KlompasDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Adi GundlapalliCDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Deblina DattaCDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Aaron M HarrisCDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sapna Bamrah MorrisCDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pavithra NatarajanCDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Sameer S KadriCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.ORCID 0000-0002-4420-9004

Funding

Preclinical and Clinical Investigations of Severe Infection and Critical Illness ZIACL008060 · CLC · CLINICAL CENTER · PI DANNER, ROBERT L · 2009 to 2025
$0k
6 · The paper itself

Abstract

In a retrospective cohort study, among 131 773 patients with previous coronavirus disease 2019 (COVID-19), reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was suspected in 253 patients (0.2%) at 238 US healthcare facilities between 1 June 2020 and 28 February 2021. Women displayed a higher cumulative reinfection risk. Healthcare burden and illness severity were similar between index and reinfection encounters.

Indexed as

COVID-19SARS-CoV-2Delivery of Health CareFemaleHumansIncidenceReinfectionRetrospective Studies

Identifiers

PMID34351392
PMCPMC8436398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.